高级检索

    中性粒细胞/淋巴细胞比值对高龄急性心肌梗死患者新发心力衰竭的预测价值

    Prognostic value of neutrophil/lymphocyte ratio in new-onset heart failure in elderly patients with acute myocardial infarction

    • 摘要: 目的 探讨中性粒细胞/淋巴细胞比值(NLR)在高龄急性非ST段抬高型心肌梗死(NSTEMI)非血运重建治疗患者新发心力衰竭的预测价值。方法 回顾性收集164例高龄NSTEMI非血运重建患者的基本信息、实验室检测结果等相关指标,观察入院后新发心力衰竭情况,根据有无新发心力衰竭情况,将其分2组。比较2组患者临床特征,采用Logistic回归分析影响新发心力衰竭发生的因素,ROC曲线进一步评估预测价值。结果 高龄NSTEMI非血运重建治疗患者新发心力衰竭的发生率为53.66%;新发心力衰竭组NLR显著高于未发生组(P<0.05)。多因素Logistic回归分析显示NLR是高龄NSTEMI非血运重建治疗患者新发心力衰竭的独立危险因素(HR=1.158,95%CI:1.040~1.290,P=0.008),ROC曲线下面积为0.780(95% CI:0.706~0.855),P<0.01;最佳截断值5.98,灵敏度71.2%,特异度76.2%。结论 NLR可以作为评价高龄NSTEMI非血运重建治疗患者新发心力衰竭的预测指标。

       

      Abstract: Objective To investigate the predictive value of neutrophil/lymphocyte ratio (NLR) in new-onset heart failure in elderly patients with acute non-ST-segment elevation myocardial infarction (NSTEMI) without revascularization therapy. Methods A total of 164 elderly patients with acute NSTEMI without revascularization were enrolled and their basic information and laboratory examination results were retrospectively analyzed. According to the presence of new heart failure, they were divided into two groups. Both groups were compared for clinical characteristics. Logistic regression analysis was performed to analyze the influence factors of new heart failure occurs. A ROC curve was plotted to evaluate predictive value. Results The incidence of new heart failure in elderly patients with acute NSTEMI without revascularization was 53.66%. The new heart failure group presented a remarkably higher NLR than those without heart failure(P<0.05). Multivariate Logistic regression analysis showed that NLR was an independent risk factor for new-onset heart failure in elderly patients with acute NSTEMI without revascularization (HR=1.158, 95%CI:1.040-1.290, P=0.008). The area under the ROC curve was 0.780 (95%CI: 0.706-0.855, P<0.01), with an optimal cutoff of 5.98, a sensitivity of 71.2% and a specificity of 76.2%. Conclusions NLR can be used as a predictor of new heart failure in elderly patients with NSTEMI without revascularization therapy.

       

    /

    返回文章
    返回